Edaravone attenuates carbonyl-stress-driven ApoA-I carboxymethylation and macrophage cholesterol-handling dysfunction in diabetic atherosclerosis.
- DOI
- 10.1016/j.freeradbiomed.2026.07.044
- Published
- 2026 Nov
- Container
- Free radical biology & medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.freeradbiomed.2026.07.044,
title = {Edaravone attenuates carbonyl-stress-driven ApoA-I carboxymethylation and macrophage cholesterol-handling dysfunction in diabetic atherosclerosis.},
author = {Ma HC and Xu YX and Zhang ZR and Zhang LF and Zhou XF and Luo HY and Xiong NQ and Song KC and Pu LJ},
year = {2026},
journal = {Free radical biology \& medicine},
doi = {10.1016/j.freeradbiomed.2026.07.044},
url = {https://doi.org/10.1016/j.freeradbiomed.2026.07.044}
}RIS
TY - JOUR TI - Edaravone attenuates carbonyl-stress-driven ApoA-I carboxymethylation and macrophage cholesterol-handling dysfunction in diabetic atherosclerosis. AU - Ma HC AU - Xu YX AU - Zhang ZR AU - Zhang LF AU - Zhou XF AU - Luo HY AU - Xiong NQ AU - Song KC AU - Pu LJ PY - 2026 JO - Free radical biology & medicine DO - 10.1016/j.freeradbiomed.2026.07.044 UR - https://doi.org/10.1016/j.freeradbiomed.2026.07.044 ER -
APA
HC, M., YX, X., ZR, Z., LF, Z., XF, Z., HY, L., NQ, X., KC, S., & LJ, P. (2026). Edaravone attenuates carbonyl-stress-driven ApoA-I carboxymethylation and macrophage cholesterol-handling dysfunction in diabetic atherosclerosis.. Free radical biology & medicine. https://doi.org/10.1016/j.freeradbiomed.2026.07.044
Source records
- pubmed · retrieved 2026-09-26T07:20:44.026Z